The FDA announced on 2015-08-25 that Hospira Inc. is recalling 1% Lidocaine HCl Injection Vials due to particulate matter, specifically iron oxide, found in the glass vial necks. Owners should stop using the product immediately.
How to tell if you have it
- Brand: Hospira
- Product: 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free
- NDC: 0409-4279-02
- Lot #: 44-359-DK
- Expiration Date: Exp 08/01/2016
The hazard
The recall addresses the presence of particulate matter identified as iron oxide embedded in the neck of glass vials. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include Asclemed Lidocaine HCl Injection Recall (2026-06-08), American Regent Papaverine HCl Injection Recall (2026-07-24), and Fresenius Kabi Lidocaine HCl Injection Recall (2026-07-16).